Pliant Therapeutics Stock Options

PLRX Stock  USD 1.54  0.02  1.32%   

Pliant Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

Pliant Total Stockholder Equity

Total Stockholder Equity

216.58 Million

At this time, Pliant Therapeutics' Total Stockholder Equity is fairly stable compared to the past year.

Pliant Therapeutics Corporate Management

Hal MDScientific BoardProfile
Mike OuimetteGen SecProfile
Rik DerynckScientific BoardProfile
Dean MDScientific BoardProfile
Johannes HullChief OfficerProfile
MBA MDCEO PresProfile
Christopher KeenanVice CommunicationsProfile

Additional Tools for Pliant Stock Analysis

When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.